Image

Overfeeding Induced Fat-tissue Stimulation

Overfeeding Induced Fat-tissue Stimulation

Recruiting
18-40 years
All
Phase N/A

Powered by AI

Overview

Type 2 diabetes is the most common metabolic disease worldwide, characterized by hyperglycemia, decreased whole body insulin sensitivity, and white adipose tissue (WAT) dysfunction. A key factor in its development is chronic overnutrition, usually with a high-fat diet (HFD), leading to disturbances of glucose and lipid metabolism. However, the mechanism of short-term HFD-induced tissue-specific insulin resistance remains poorly understood. This project aims to further unravel the underlying mechanisms of short-term HFD overnutrition-mediated WAT insulin resistance. The model described here corresponds to a randomized, single- blinded parallel-grouped trial, consisting of two interventions: a macronutrient-balanced diet and or a hypercaloric diet over three weeks in order to investigate differences in interorgan fatty acid and glucose metabolism between the studied groups. Based on recent studies, the hypothesis is that 21-day hypercaloric HFD induces WAT insulin resistance via a diacylglycerol, novel protein kinase C-insulin receptor signaling model in both fasting and insulin-stimulated states.

Eligibility

Inclusion Criteria:

  • Age between 18 and 40 years
  • BMI < 29 kg/m2
  • Sport inactive (<1x /week)
  • Capacity to consent

Exclusion Criteria:

  • Diabetes mellitus disease
  • Acute coronary heart syndrome (myocardial infarction, unstable angina pectoris, stroke or transient ischemic attack in the last 3 months before study participation)
  • Acute infectious disease
  • Taking blood glucose-lowering drugs
  • Diseases or drugs affecting the immune system and allergies to drugs used in the study
  • Drugs with potential metabolic effects
  • Chronic liver disease (hepatitis, gallbladder disease, elevated liver enzymes (ALT > 300 U/L))
  • Chronic inflammatory bowel diseases
  • Rheumatic diseases
  • Hyper- or hypothyroidism of the thyroid gland
  • Renal insufficiency, administration of iodine-containing contrast media in the last 2 days
  • Chronic lung diseases
  • cancerous diseases
  • Addictive diseases, psychiatric diseases
  • Pregnancy, breastfeeding
  • Shift workers
  • Anemia (Hb <12 g/dl)
  • Disorders of hemostasis
  • Regular use of antithrombotic drugs
  • Alcohol consumption, smoking
  • Conditions that do not permit an MRI examination

Study details
    Lipid-induced Insulin Resistance

NCT06193668

German Diabetes Center

28 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.